![Kevin Waters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 3 M $ in data 30/06/2026
Kevin Waters is Chief Financial Officer & Executive Vice President at PROCEPT BioRobotics Corp.
since 2022, with employment at the company starting in 2018.
Former roles include Chief Financial Officer & Senior Vice President at Accuray, Inc. from 2015 to 2018; Vice President-Finance & Controller at Conceptus, Inc. from 2006 to 2011; Vice President-Finance & Controller at Conceptus SAS in 2012; Controller at Laserscope, Inc. in 2006; Finance Director at AMO Manufacturing USA LLC in 2005; and Director positions at TriSalus Operating Life Sciences, Inc. and Qool Therapeutics, Inc. Education includes undergraduate studies at California Polytechnic State University (San Luis Obispo).
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/06/2026 | 151.201 ( 0,27% ) | 3 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PROCEPT BIOROBOTICS CORPORATION | Direttore Finanziario/CFO | 01/10/2018 |
| Società | Posizione | Fine |
|---|---|---|
| ACCURAY INCORPORATED | Direttore Finanziario/CFO | 01/10/2018 |
Laserscope, Inc.
 Laserscope, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, markets and supports surgical lasers and other surgical systems | Comptroller/Controller/Auditor | 01/01/2006 |
AMO Manufacturing USA LLC
 AMO Manufacturing USA LLC Medical SpecialtiesHealth Technology Designs, develops and manufactures excimer refractive surgical systems | Direttore Finanziario/CFO | 01/01/2005 |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Direttore/Membro del Consiglio | - |
Qool Therapeutics, Inc.
 Qool Therapeutics, Inc. BiotechnologyHealth Technology Develops non-invasive temperature management therapies to induce therapeutic hypothermia | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Laserscope, Inc.
Laserscope, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, markets and supports surgical lasers and other surgical systems | Health Technology |
AMO Manufacturing USA LLC
AMO Manufacturing USA LLC Medical SpecialtiesHealth Technology Designs, develops and manufactures excimer refractive surgical systems | Health Technology |
Conceptus, Inc.
 Conceptus, Inc. Medical SpecialtiesHealth Technology Develops and markets minimally invasive devices for reproductive medical applications | Health Technology |
PROCEPT BioRobotics Corp.
 PROCEPT BioRobotics Corp. Medical SpecialtiesHealth Technology Develops robotic therapy systems for the treatment of lower urinary tract symptoms | Health Technology |
Accuray, Inc.
 Accuray, Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Conceptus SAS
 Conceptus SAS Medical SpecialtiesHealth Technology Designs, develops and markets innovative medical products | Health Technology |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for treatment of liver and pancreatic tumors | Health Technology |
Qool Therapeutics, Inc.
Qool Therapeutics, Inc. BiotechnologyHealth Technology Develops non-invasive temperature management therapies to induce therapeutic hypothermia | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
